{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:26:12Z","timestamp":1791177972471,"version":"4.1.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.hoc.2015.01.007","type":"journal-article","created":{"date-parts":[[2015,5,29]],"date-time":"2015-05-29T04:06:44Z","timestamp":1432872404000},"page":"525-539","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Shiga Toxin Associated Hemolytic Uremic Syndrome"],"prefix":"10.1016","volume":"29","author":[{"given":"Lindsay Susan","family":"Keir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.hoc.2015.01.007_bib1","doi-asserted-by":"crossref","first-page":"e673","DOI":"10.1542\/peds.2004-2236","article-title":"Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion","volume":"115","author":"Ake","year":"2005","journal-title":"Pediatrics"},{"issue":"112","key":"10.1016\/j.hoc.2015.01.007_bib2","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1038\/ki.2008.624","article-title":"Treatment options for HUS secondary to Escherichia coli O157:H7","author":"Bitzan","year":"2009","journal-title":"Kidney Int Suppl"},{"issue":"6","key":"10.1016\/j.hoc.2015.01.007_bib3","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0031-3955(16)40096-9","article-title":"The hemolytic uremic syndrome","volume":"42","author":"Siegler","year":"1995","journal-title":"Pediatr Clin North Am"},{"issue":"10","key":"10.1016\/j.hoc.2015.01.007_bib4","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/cid\/cis196","article-title":"Need for long-term follow-up in enterohemorrhagic Escherichia coli-associated hemolytic uremic syndrome due to late-emerging sequelae","volume":"54","author":"Rosales","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.hoc.2015.01.007_bib5","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1056\/NEJMc0809959","article-title":"Eculizumab for congenital atypical hemolytic-uremic syndrome","volume":"360","author":"Gruppo","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.hoc.2015.01.007_bib6","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1089\/fpd.2013.1704","article-title":"Global incidence of human Shiga toxin-producing Escherichia coli infections and deaths: a systematic review and knowledge synthesis","volume":"11","author":"Majowicz","year":"2014","journal-title":"Foodborne Pathog Dis"},{"issue":"1","key":"10.1016\/j.hoc.2015.01.007_bib7","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3201\/eid1701.P21101","article-title":"Foodborne illness acquired in the United States\u2013unspecified agents","volume":"17","author":"Scallan","year":"2011","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"10.1016\/j.hoc.2015.01.007_bib8","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/MOG.0b013e3282f2dfb8","article-title":"Pathogenesis and treatment of Shiga toxin-producing Escherichia coli infections","volume":"24","author":"Serna","year":"2008","journal-title":"Curr Opin Gastroenterol"},{"issue":"10","key":"10.1016\/j.hoc.2015.01.007_bib9","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1111\/j.1462-2920.2010.02293.x","article-title":"Cattle, weather and water: mapping Escherichia coli O157:H7 infections in humans in England and Scotland","volume":"12","author":"Money","year":"2010","journal-title":"Environ Microbiol"},{"issue":"10","key":"10.1016\/j.hoc.2015.01.007_bib10","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1007\/s00467-008-0935-6","article-title":"Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS)","volume":"23","author":"Scheiring","year":"2008","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"10.1016\/j.hoc.2015.01.007_bib11","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/INF.0b013e31827ca763","article-title":"Estimates of illnesses, hospitalizations and deaths caused by major bacterial enteric pathogens in young children in the United States","volume":"32","author":"Scallan","year":"2013","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10.1016\/j.hoc.2015.01.007_bib12","doi-asserted-by":"crossref","first-page":"e59209","DOI":"10.1371\/journal.pone.0059209","article-title":"Risk factors for development of hemolytic uremic syndrome in a cohort of adult patients with STEC 0104:H4 infection","volume":"8","author":"Zoufaly","year":"2013","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.hoc.2015.01.007_bib13","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.3201\/eid1112.050607","article-title":"Hemolytic uremic syndrome risk and Escherichia coli O157:H7","volume":"11","author":"Tserenpuntsag","year":"2005","journal-title":"Emerg Infect Dis"},{"issue":"7","key":"10.1016\/j.hoc.2015.01.007_bib14","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.2215\/CJN.08921209","article-title":"Acute neurological involvement in diarrhea-associated hemolytic uremic syndrome","volume":"5","author":"Nathanson","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"10.1016\/j.hoc.2015.01.007_bib15","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s00467-003-1262-6","article-title":"Risk factors for poor renal prognosis in children with hemolytic uremic syndrome","volume":"18","author":"Gianviti","year":"2003","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"10.1016\/j.hoc.2015.01.007_bib16","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1046\/j.1523-1755.2001.060003831.x","article-title":"Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura","volume":"60","author":"Ruggenenti","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.hoc.2015.01.007_bib17","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1146\/annurev.pathmechdis.3.121806.154311","article-title":"Pathogenesis of thrombotic microangiopathies","volume":"3","author":"Zheng","year":"2008","journal-title":"Annu Rev Pathol"},{"issue":"7","key":"10.1016\/j.hoc.2015.01.007_bib18","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1093\/ndt\/gfs279","article-title":"Thrombotic microangiopathy and associated renal disorders","volume":"27","author":"Barbour","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"10.1016\/j.hoc.2015.01.007_bib19","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1007\/s00467-010-1522-1","article-title":"Shiga toxin-associated hemolytic uremic syndrome: pathophysiology of endothelial dysfunction","volume":"25","author":"Zoja","year":"2010","journal-title":"Pediatr Nephrol"},{"issue":"11","key":"10.1016\/j.hoc.2015.01.007_bib20","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.1128\/IAI.00620-10","article-title":"Human intestinal tissue and cultured colonic cells contain globotriaosylceramide synthase mRNA and the alternate Shiga toxin receptor globotetraosylceramide","volume":"78","author":"Zumbrun","year":"2010","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.hoc.2015.01.007_bib21","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00018-012-1060-z","article-title":"Facing glycosphingolipid-Shiga toxin interaction: dire straits for endothelial cells of the human vasculature","volume":"70","author":"Bauwens","year":"2013","journal-title":"Cell Mol Life Sci"},{"issue":"10","key":"10.1016\/j.hoc.2015.01.007_bib22","doi-asserted-by":"crossref","first-page":"6148","DOI":"10.1128\/IAI.69.10.6148-6155.2001","article-title":"Shiga toxin translocation across intestinal epithelial cells is enhanced by neutrophil transmigration","volume":"69","author":"Hurley","year":"2001","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.hoc.2015.01.007_bib23","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/INF.0b013e3182074d22","article-title":"Clinical relevance of shiga toxin concentrations in the blood of patients with hemolytic uremic syndrome","volume":"30","author":"Brigotti","year":"2011","journal-title":"Pediatr Infect Dis J"},{"issue":"Pt 11","key":"10.1016\/j.hoc.2015.01.007_bib24","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1099\/jmm.0.47282-0","article-title":"Differential binding of Shiga toxin 2 to human and murine neutrophils","volume":"56","author":"Griener","year":"2007","journal-title":"J\u00a0Med Microbiol"},{"issue":"3","key":"10.1016\/j.hoc.2015.01.007_bib25","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1538-7933.2004.00638.x","article-title":"Shiga toxin binds to activated platelets","volume":"2","author":"Ghosh","year":"2004","journal-title":"J\u00a0Thromb Haemost"},{"issue":"8","key":"10.1016\/j.hoc.2015.01.007_bib26","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1128\/iai.62.8.3337-3347.1994","article-title":"Evidence that verotoxins (Shiga-like toxins) from Escherichia coli bind to P blood group antigens of human erythrocytes in\u00a0vitro","volume":"62","author":"Bitzan","year":"1994","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.hoc.2015.01.007_bib27","doi-asserted-by":"crossref","first-page":"626","DOI":"10.3390\/toxins3060626","article-title":"Shiga toxin interaction with human intestinal epithelium","volume":"3","author":"Sch\u00fcller","year":"2011","journal-title":"Toxins (Basel)"},{"issue":"9","key":"10.1016\/j.hoc.2015.01.007_bib28","doi-asserted-by":"crossref","first-page":"4748","DOI":"10.4049\/jimmunol.1300122","article-title":"Identification of TLR4 as the receptor that recognizes Shiga toxins in human neutrophils","volume":"191","author":"Brigotti","year":"2013","journal-title":"J\u00a0Immunol"},{"issue":"2","key":"10.1016\/j.hoc.2015.01.007_bib29","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nrmicro2279","article-title":"Shiga toxins\u2013from cell biology to biomedical applications","volume":"8","author":"Johannes","year":"2010","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.hoc.2015.01.007_bib30","first-page":"19","article-title":"How ricin and Shiga toxin reach the cytosol of target cells: retrotranslocation from the endoplasmic reticulum","volume":"357","author":"Spooner","year":"2012","journal-title":"Curr Top Microbiol Immunol"},{"issue":"2","key":"10.1016\/j.hoc.2015.01.007_bib31","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1525-139X.2011.01035.x","article-title":"Thrombotic microangiopathy: current knowledge and outcomes with plasma exchange","volume":"25","author":"Clark","year":"2012","journal-title":"Semin Dial"},{"issue":"18","key":"10.1016\/j.hoc.2015.01.007_bib32","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1182\/blood-2010-02-271957","article-title":"Shiga toxin B subunits induce VWF secretion by human endothelial cells and thrombotic microangiopathy in ADAMTS13-deficient mice","volume":"116","author":"Huang","year":"2010","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.hoc.2015.01.007_bib33","doi-asserted-by":"crossref","first-page":"5985","DOI":"10.1128\/IAI.67.11.5985-5993.1999","article-title":"Shiga toxins stimulate secretion of interleukin-8 from intestinal epithelial cells","volume":"67","author":"Thorpe","year":"1999","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.hoc.2015.01.007_bib34","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1096\/fj.01-0521com","article-title":"Damage to nuclear DNA induced by Shiga toxin 1 and ricin in human endothelial cells","volume":"16","author":"Brigotti","year":"2002","journal-title":"FASEB J"},{"issue":"20","key":"10.1016\/j.hoc.2015.01.007_bib35","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.1182\/blood-2010-09-309161","article-title":"Complement activation on platelet-leukocyte complexes and microparticles in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome","volume":"117","author":"St\u00e5hl","year":"2011","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.hoc.2015.01.007_bib36","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/ndt\/gfr748","article-title":"Microparticle generation and leucocyte death in Shiga toxin-mediated HUS","volume":"27","author":"Ge","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.hoc.2015.01.007_bib37","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.tiv.2010.11.006","article-title":"Increased advanced oxidation of protein products and enhanced total antioxidant capacity in plasma by action of toxins of Escherichia coli STEC","volume":"25","author":"Aiassa","year":"2011","journal-title":"Toxicol In\u00a0Vitro"},{"issue":"3","key":"10.1016\/j.hoc.2015.01.007_bib38","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/cei.12124","article-title":"The oxidative stress induced in\u00a0vivo by shiga toxin-2 contributes to the pathogenicity of haemolytic uraemic syndrome","volume":"173","author":"Gomez","year":"2013","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"10.1016\/j.hoc.2015.01.007_bib39","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1111\/j.1523-1755.2002.kid554.x","article-title":"Protective role of nitric oxide in mice with Shiga toxin-induced hemolytic uremic syndrome","volume":"62","author":"Dran","year":"2002","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.hoc.2015.01.007_bib40","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1159\/000187063","article-title":"Hypocomplementemia and leukocytosis in diarrhea-associated hemolytic uremic syndrome","volume":"62","author":"Robson","year":"1992","journal-title":"Nephron"},{"issue":"4","key":"10.1016\/j.hoc.2015.01.007_bib41","first-page":"168","article-title":"The complement system in hemolytic-uremic syndrome in childhood","volume":"13","author":"Monnens","year":"1980","journal-title":"Clin Nephrol"},{"issue":"4","key":"10.1016\/j.hoc.2015.01.007_bib42","first-page":"845","article-title":"Breakdown products of C3 and factor B in hemolytic-uremic syndrome","volume":"89","author":"Kim","year":"1977","journal-title":"J\u00a0Lab Clin Med"},{"issue":"12","key":"10.1016\/j.hoc.2015.01.007_bib43","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.2215\/CJN.02730409","article-title":"Alternative pathway of complement in children with diarrhea-associated hemolytic uremic syndrome","volume":"4","author":"Thurman","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10","key":"10.1016\/j.hoc.2015.01.007_bib44","doi-asserted-by":"crossref","first-page":"6394","DOI":"10.4049\/jimmunol.0900151","article-title":"Shiga toxin activates complement and binds factor H: evidence for an active role of complement in hemolytic uremic syndrome","volume":"182","author":"Orth","year":"2009","journal-title":"J\u00a0Immunol"},{"issue":"1","key":"10.1016\/j.hoc.2015.01.007_bib45","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.molimm.2013.11.009","article-title":"Interaction of Shiga toxin 2 with complement regulators of the factor H protein family","volume":"58","author":"Poolpol","year":"2014","journal-title":"Mol Immunol"},{"issue":"6","key":"10.1016\/j.hoc.2015.01.007_bib46","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1084\/jem.20070301","article-title":"Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains","volume":"204","author":"Pickering","year":"2007","journal-title":"J\u00a0Exp Med"},{"issue":"8","key":"10.1016\/j.hoc.2015.01.007_bib47","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1128\/IAI.01079-12","article-title":"Shiga toxin 2 reduces complement inhibitor CD59 expression on human renal tubular epithelial and glomerular endothelial cells","volume":"81","author":"Ehrlenbach","year":"2013","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.hoc.2015.01.007_bib48","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1007\/s00467-003-1236-8","article-title":"Decrease of thrombomodulin contributes to the procoagulant state of endothelium in hemolytic uremic syndrome","volume":"18","author":"Fern\u00e1ndez","year":"2003","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"10.1016\/j.hoc.2015.01.007_bib49","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4049\/jimmunol.1100491","article-title":"Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis","volume":"187","author":"Morigi","year":"2011","journal-title":"J\u00a0Immunol"},{"issue":"6","key":"10.1016\/j.hoc.2015.01.007_bib50","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s004670050644","article-title":"Markers of endothelial cell activation and injury in childhood haemolytic uraemic syndrome","volume":"13","author":"Nevard","year":"1999","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"10.1016\/j.hoc.2015.01.007_bib51","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1046\/j.1523-1755.2002.00502.x","article-title":"Differential tissue targeting and pathogenesis of verotoxins 1 and 2 in the mouse animal model","volume":"62","author":"Rutjes","year":"2002","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.hoc.2015.01.007_bib52","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1365-2249.2008.03826.x","article-title":"Shiga toxin-2 results in renal\u00a0tubular injury but not thrombotic microangiopathy in heterozygous factor H-deficient\u00a0mice","volume":"155","author":"Paix\u00e3o-Cavalcante","year":"2009","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"10.1016\/j.hoc.2015.01.007_bib53","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0882-4010(90)90083-3","article-title":"Evidence for participation of the macrophage in Shiga-like toxin II-induced lethality in mice","volume":"9","author":"Barrett","year":"1990","journal-title":"Microb Pathog"},{"issue":"12","key":"10.1016\/j.hoc.2015.01.007_bib54","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1681\/ASN.2006050419","article-title":"A\u00a0murine model of HUS: Shiga toxin with lipopolysaccharide mimics the renal damage and physiologic response of human disease","volume":"17","author":"Keepers","year":"2006","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"7","key":"10.1016\/j.hoc.2015.01.007_bib55","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.4049\/jimmunol.1102118","article-title":"Lack of the lectin-like domain of thrombomodulin worsens Shiga toxin-associated hemolytic uremic syndrome in mice","volume":"189","author":"Zoja","year":"2012","journal-title":"J\u00a0Immunol"},{"issue":"8","key":"10.1016\/j.hoc.2015.01.007_bib56","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1681\/ASN.2013050450","article-title":"Shiga toxin promotes podocyte injury in experimental hemolytic uremic syndrome via activation of the alternative pathway of complement","volume":"25","author":"Locatelli","year":"2014","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"11","key":"10.1016\/j.hoc.2015.01.007_bib57","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1007\/s00467-012-2383-6","article-title":"Long-term outcomes of Shiga toxin hemolytic uremic syndrome","volume":"28","author":"Spinale","year":"2013","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"10.1016\/j.hoc.2015.01.007_bib58","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1053\/j.ajkd.2008.07.038","article-title":"Interventions for hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: a systematic review of randomized controlled trials","volume":"53","author":"Michael","year":"2009","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.hoc.2015.01.007_bib59","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0022-3476(88)80071-4","article-title":"Plasma infusion for hemolytic-uremic syndrome in children: results of a multicenter controlled trial","volume":"112","author":"Rizzoni","year":"1988","journal-title":"J\u00a0Pediatr"},{"issue":"3","key":"10.1016\/j.hoc.2015.01.007_bib60","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF00858677","article-title":"Treatment of the childhood haemolytic uraemic syndrome with plasma. A multicentre randomized controlled trial. The French Society of Paediatric Nephrology","volume":"2","author":"Loirat","year":"1988","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.hoc.2015.01.007_bib61","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJMra0902814","article-title":"Atypical hemolytic uremic syndrome","volume":"361","author":"Noris","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.hoc.2015.01.007_bib62","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00467-011-2067-7","article-title":"Outbreak of hemolytic uremic syndrome caused by E. coli O104:H4 in Germany: a pediatric perspective","volume":"27","author":"Kemper","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.hoc.2015.01.007_bib63","doi-asserted-by":"crossref","first-page":"e4565","DOI":"10.1136\/bmj.e4565","article-title":"Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study","volume":"345","author":"Menne","year":"2012","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.hoc.2015.01.007_bib64","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/cid\/cis531","article-title":"An outbreak of Shiga toxin-producing Escherichia coli O104:H4 hemolytic uremic syndrome in Germany: presentation and short-term outcome in children","volume":"55","author":"Loos","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"9796","key":"10.1016\/j.hoc.2015.01.007_bib65","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0140-6736(11)61145-8","article-title":"Management of an acute outbreak of diarrhoea-associated haemolytic uraemic syndrome with early plasma exchange in adults from southern Denmark: an observational study","volume":"378","author":"Colic","year":"2011","journal-title":"Lancet"},{"issue":"26","key":"10.1016\/j.hoc.2015.01.007_bib66","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1056\/NEJMc1100859","article-title":"Eculizumab in severe Shiga-toxin-associated HUS","volume":"364","author":"Lapeyraque","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"9797","key":"10.1016\/j.hoc.2015.01.007_bib67","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/S0140-6736(11)61253-1","article-title":"Treatment of severe neurological deficits with IgG depletion through immunoadsorption in patients with Escherichia coli O104:H4-associated haemolytic uraemic syndrome: a prospective trial","volume":"378","author":"Greinacher","year":"2011","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.hoc.2015.01.007_bib68","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1093\/ndt\/gfs394","article-title":"Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic-uraemic syndrome: an analysis of the German STEC-HUS registry","volume":"27","author":"Kielstein","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"10.1016\/j.hoc.2015.01.007_bib69","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1007\/s00108-012-3107-5","article-title":"Treatment of typical hemolytic-uremic syndrome: knowledge gained from analyses of the 2011 E. coli outbreak","volume":"53","author":"Menne","year":"2012","journal-title":"Internist (Berl)"},{"issue":"10","key":"10.1016\/j.hoc.2015.01.007_bib70","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1001\/jama.2012.264","article-title":"Association between azithromycin therapy and duration of bacterial shedding among patients with Shiga toxin-producing enteroaggregative Escherichia coli O104:H4","volume":"307","author":"Nitschke","year":"2012","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.hoc.2015.01.007_bib71","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/ndt\/gft470","article-title":"Outbreak of Escherichia coli O104:H4 haemolytic uraemic syndrome in France: outcome with eculizumab","volume":"29","author":"Delmas","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.hoc.2015.01.007_bib72","doi-asserted-by":"crossref","first-page":"590","DOI":"10.3201\/eid1104.040833","article-title":"Childhood hemolytic uremic syndrome, United Kingdom and Ireland","volume":"11","author":"Lynn","year":"2005","journal-title":"Emerg Infect Dis"},{"issue":"10","key":"10.1016\/j.hoc.2015.01.007_bib73","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1001\/jama.290.10.1360","article-title":"Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression","volume":"290","author":"Garg","year":"2003","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.hoc.2015.01.007_bib74","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1053\/j.ajkd.2007.10.042","article-title":"Albuminuria and estimated GFR 5 years after Escherichia coli O157 hemolytic uremic syndrome: an update","volume":"51","author":"Garg","year":"2008","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.hoc.2015.01.007_bib75","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000357520","article-title":"A\u00a0case of atypical hemolytic uremic syndrome successfully treated with eculizumab","volume":"3","author":"Thajudeen","year":"2013","journal-title":"Case Rep Nephrol Urol"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858815000088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858815000088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:01:29Z","timestamp":1760184089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858815000088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":75,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0889858815000088"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2015.01.007","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Shiga Toxin Associated Hemolytic Uremic Syndrome","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2015.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}